ExecPay

Mark Avagliano

Overview2022202120202019

Overview

Mark Avagliano received an average of $2M in total compensation, including $381K in salary, at G1 Therapeutics from 2019 to 2022.

Source: SEC filings on April 26, 2023, April 28, 2021, and April 24, 2020.
Avagliano's 2022 pay

Related executives

We found nine more executives who work or worked at G1 Therapeutics.

John Bailey

G1 Therapeutics

Chief Executive Officer

3

Jennifer Moses

G1 Therapeutics

Chief Financial Officer

4

Mark Velleca

G1 Therapeutics

Chief Executive Officer

5

Soma Gupta

G1 Therapeutics

Chief Commercial Officer

1

Rajesh Malik

G1 Therapeutics

Chief Medical Officer

4

John Demaree

G1 Therapeutics

Chief Commercial Officer

2

Barclay Phillips

G1 Therapeutics

Chief Financial Officer

3

James Hanson

G1 Therapeutics

General Counsel

1

News

You may also like

G1 Therapeutics